CTLA4 and neoplasm: The elevated levels of lactate can further support the proliferation of tumor-infiltrating regulatory T cells (Tregs) and enhance Treg-mediated anti-tumor immunity, thereby decreasing the sensitivity of CRC to anti-CTLA-4 therapy (D9D).